|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.07.26 - 00:30
|
Pfizer-Aktie: Dividende unter der Lupe – sind 7% Rendite nachhaltig? (Sharedeals)
|
|
|
Pfizer zählt derzeit zu den dividendenstärksten Pharmakonzernen an der Wall Street und lockt Anleger mit einer Rendite von rund sieben Prozent. Doch angesichts rückläufiger Gewinne und einer hohen Ausschüttungsquote stellt sich die Frage, wie nachhaltig diese Dividendenpolitik tatsächlich ist. Ein genauer Blick auf die Finanzlage und die Produktpipeline liefert darauf eine differenziertere Antwort. Hohe Dividendenrendite […]
The post Pfizer-Aktie: Dividende unter der Lupe – sind 7% Rendite nachhaltig? first appeared on sharedeals.de....
|
|
|
|
|
|
|
23.07.26 - 13:03
|
Verdiva Bio Appoints Cardiometabolic Leader Steve Marso as Chief Medical Officer (Business Wire)
|
|
|
Steve Marso, M.D., joins Verdiva as CMO from Metsera, where he held the equivalent position, bringing valuable clinical and regulatory expertise as Verdiva continues development of a unique portfolio of once-weekly oral treatments for obesity
Also from Metsera, Jason Mallory joins Verdiva as SVP, Clinical Development to lead Verdiva's clinical trial design and execution
LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Verdiva Bio Limited (“Verdiva Bio” or the “Company”), a clinical-stage biotechnology company advancing the development of a portfolio of once-weekly oral therapies for obesity and obesity-related disorders, today announced that it has strengthened its leadership team with the appointment of Steve Marso, M.D. as Chief Medical Officer (CMO). Steve brings valuable clinical and regulatory experience to Verdiva following his previous roles, including as CMO at Metsera from May 2023 through to its acquisition by Pfizer in November 2025. He will lead Verdiva's clinical strategy and execution, dri...
|
|
|
22.07.26 - 23:51
|
XETR: DIVIDEND/INTEREST INFORMATION - 24.07.2026 - US7170811035 (XETRA)
|
|
|
Das Instrument PFE US7170811035 PFIZER INC. DL-,05 EQUITY wird cum Dividende/Zinsen gehandelt am 23.07.2026 und ex Dividende/Zinsen am 24.07.2026
The instrument PFE US7170811035 PFIZER INC. DL-,05 EQUITY has its pre-dividend/interest day on 23.07.2026 and its ex-dividend/interest day on 24.07.2026...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
